Mergers & Acquisitions - Valeant Pharmaceuticals

Filter

Current filters:

Valeant Pharmaceuticals

Popular Filters

1 to 25 of 32 results

Allergan warns shareholders to take no action ahead of Valeant calling ‘special meeting’

Allergan warns shareholders to take no action ahead of Valeant calling ‘special meeting’

03-06-2014

Takeover target USA-based Allergan has responded to action taken by Canadian drugmaker Valeant Pharmaceuticals…

AllerganBusiness FinanceMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

Valeant ups offer for Allergan as target publishes attack on its business model

Valeant ups offer for Allergan as target publishes attack on its business model

28-05-2014

Canadian drugmaker Valeant Pharmaceuticals International has today upped its offer for USA-based Allergan…

AllerganBusiness FinanceBusiness FinanceCanadaMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

Valeant Pharma to sell filler and toxin assets to Nestle for $1.4 billion

Valeant Pharma to sell filler and toxin assets to Nestle for $1.4 billion

28-05-2014

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International has entered into an agreement to…

DermatologicalsGaldermaMergers & AcquisitionsNestlePharmaceuticalValeant Pharmaceuticals

Allergan board totally rejects Valeant’s $46 billion bid

Allergan board totally rejects Valeant’s $46 billion bid

13-05-2014

USA-based Allergan said yesterday that its board of directors has unanimously rejected the $46 billion…

AllerganMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Takeover target Allergen reports strong 1st-qtr sales growth

07-05-2014

US drugmaker Allergan reported a strong set of first-quarter 2014 financial results, with global sales…

AllerganFinancialMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Allergan adopts stockholder rights plan

23-04-2014

USA-based Allergan, the subject of a hostile takeover bid from Canada’s Valeant Pharmaceuticals reported…

AllerganFinancialMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Valeant joins with hedge fund in $45.6 billion unsolicited bid for Allergan

22-04-2014

Canada’s Valeant Pharmaceuticals International, never shy to go for hostile takeover moves, says it…

AllerganMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Valeant spending $475 million to boost dermatology portfolio

Valeant spending $475 million to boost dermatology portfolio

03-02-2014

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International has entered into a definitive agreement…

DermatologicalsMergers & AcquisitionsPharmaceuticalPreCision DermatologyValeant Pharmaceuticals

Valeant confirms plan to acquire Bausch & Lomb in a $8.7 billion transaction

28-05-2013

Following speculation ahead of the extended holiday weekend, acquisitive Canadian drugmaker Valeant Pharmaceuticals…

Bausch & LombMergers & AcquisitionsOphthalmicsPharmaceuticalValeant Pharmaceuticals

Actavis in OxyContin patent settlement; Valeant takeover bid "on hold"?

29-04-2013

US generic major Actavis (NYSE: ACT) has entered into an agreement with privately-held Purdue Pharma…

ActavisGenericsMergers & AcquisitionsNeurologicalNorth AmericaOxyContinPatentsPurdue PharmaValeant Pharmaceuticals

Merz Pharma enters bidding war for Obagi; Ferro sells pharma unit

02-04-2013

German family-owned firm Merz Pharma has written to the board of director of Obagi Medical Products outlining…

Ferro GroupGenericsMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPfanstiehl LaboratoriesPharmaceuticalValeant Pharmaceuticals

Valeant to acquire Obagi Medical for around $344 million

20-03-2013

Canada-based Valeant Pharmaceuticals International (TSX: VRX) is on the acquisition trail again, announcing…

DermatologicalsMergers & AcquisitionsObagi Medical ProductsPharmaceuticalValeant Pharmaceuticals

Valeant may pull out of Russian Natur Produkt acquisition

02-10-2012

According to local sources in Russia, acquisitive Canadian drugmaker Valeant Pharmaceuticals (TSX: VRX)…

Mergers & AcquisitionsNatur ProduktPharmaceuticalValeant Pharmaceuticals

Valeant Pharma acquires Visudyne from QLT

25-09-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) said yesterday that it…

Mergers & AcquisitionsOphthalmicsPharmaceuticalQLTValeant PharmaceuticalsVisudyne

Valeant on the prowl again, with bid to buy Medicis for about $2.6 billion

04-09-2012

In a sixth acquisition so far this year, as well as several takeovers the previous year, Canada's Valeant…

DermatologicalsMedicis PharmaceuticalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Valeant goes shopping again, this time for OraPharma

18-06-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) said Friday that it has…

FinancialMergers & AcquisitionsOraPharmaPharmaceuticalValeant Pharmaceuticals

Valeant Pharma to acquire assets from University Medical; posts 1st-qtr loss

04-05-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has agreed to…

FinancialMergers & AcquisitionsPharmaceuticalUniversity Medical PharmaValeant Pharmaceuticals

Valeant Pharma to acquire assets in Mexico; Mylan invests in Ireland

19-04-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

Atlantis PharmaEuropeFinancialGenericsMergers & AcquisitionsMylan LaboratoriesSouth AmericaValeant Pharmaceuticals

Valeant Pharma to acquire podiatry firm Pedinol

13-04-2012

In a fourth takeover deal so far this year, Canadian drugmaker Valeant Pharmaceuticals International.…

Mergers & AcquisitionsPedinol PharmacalPharmaceuticalValeant Pharmaceuticals

Valeant to buy Russian OTC drugmaker

27-03-2012

In its third takeover announcement this year, Canadian drugmaker Valeant Pharmaceuticals International…

Mergers & AcquisitionsNatur ProduktPharmaceuticalValeant Pharmaceuticals

Valeant goes shopping again, buying branded generics from Gerot Lannach

14-03-2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

AspirinGenericsGerot LannachMergers & AcquisitionsValeant Pharmaceuticals

1 to 25 of 32 results

Parexel

Parexel

Back to top